Paper40428282
The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review).
Englisz A and 5 others. Diagnostics (Basel), 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review). Papers, record 40428282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40428282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review).
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9170483 | Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study. | Obstet Gynecol | 1997 | https://conductscience.org/library/papers/9170483 | PubMed |
| 2 | 33536036 | Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer. | J Transl Med | 2021 | https://conductscience.org/library/papers/33536036 | PubMed |
| 3 | 35545786 | Potential clinical utility of liquid biopsies in ovarian cancer. | Mol Cancer | 2022 | https://conductscience.org/library/papers/35545786 | PubMed |
| 4 | 15111296 | Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. | Am J Pathol | 2004 | https://conductscience.org/library/papers/15111296 | PubMed |
| 5 | 32176625 | Utility of urinary ctDNA to monitoring minimal residual disease in early breast cancer patients. | Cancer Biomark | 2020 | https://conductscience.org/library/papers/32176625 | PubMed |
| 6 | 35303879 | Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. | Mol Cancer | 2022 | https://conductscience.org/library/papers/35303879 | PubMed |
| 7 | 35138400 | Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention. | JAMA Netw Open | 2022 | https://conductscience.org/library/papers/35138400 | PubMed |
| 8 | 39335089 | The Role of Circulating Tumor DNA in Ovarian Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39335089 | PubMed |
| 9 | 38414861 | PBRM1 presents a potential ctDNA marker to monitor response to neoadjuvant chemotherapy in cervical cancer. | iScience | 2024 | https://conductscience.org/library/papers/38414861 | PubMed |
| 10 | 34111149 | Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer. | PLoS One | 2021 | https://conductscience.org/library/papers/34111149 | PubMed |
| 11 | 34022731 | HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer. | ESMO Open | 2021 | https://conductscience.org/library/papers/34022731 | PubMed |
| 12 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 13 | 34887451 | Endometrial cancer. | Nat Rev Dis Primers | 2021 | https://conductscience.org/library/papers/34887451 | PubMed |
| 14 | 30319183 | Serum Biomarker Based Algorithms in Diagnosis of Ovarian Cancer: A Review. | Indian J Clin Biochem | 2018 | https://conductscience.org/library/papers/30319183 | PubMed |
| 15 | 16137751 | Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. | Gynecol Oncol | 2006 | https://conductscience.org/library/papers/16137751 | PubMed |
| 16 | 37972346 | Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer. | J Clin Oncol | 2024 | https://conductscience.org/library/papers/37972346 | PubMed |
| 17 | 20368574 | Development of a multimarker assay for early detection of ovarian cancer. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20368574 | PubMed |
| 18 | 29416824 | The dawn of the liquid biopsy in the fight against cancer. | Oncotarget | 2018 | https://conductscience.org/library/papers/29416824 | PubMed |
| 19 | 27054934 | Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. | Obstet Gynecol | 2016 | https://conductscience.org/library/papers/27054934 | PubMed |
| 20 | 36208860 | Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer. | Biomed J | 2023 | https://conductscience.org/library/papers/36208860 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42857018 | Beyond molecular classification: integrating signaling, subcellular, and immune reprogramming in endometrial cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42857018 | PubMed |
| 42259736 | Using cell-free DNA tumor methylation score to detect and monitor cholangiocarcinoma. | HPB (Oxford) | 2026 | https://conductscience.org/library/papers/42259736 | PubMed |
| 42073573 | Biomarkers with Therapeutic or Prognostic Applications in Gynecologic Malignancies. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42073573 | PubMed |
| 41683910 | Glycomic Insights in Gynecological Disease: From Molecular Mechanisms to Precision Diagnostics and Therapeutics. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683910 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40428282
GET https://conductscience.org/api/papers/v1/40428282/references?page=2